A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could ...
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback